There’s a fascinating conversation buzzing right now across neuroscience and wel
The reel accurately describes the use of GLP-1 agonists like semaglutide for weight loss and suggests potential effects on addiction, which is supported by some studies. However, the claim about these supplements affecting the ability to fall in love is speculative and lacks scientific evidence.
This ingredient is not in our library. We cannot assess claims about it.
This ingredient is not in our library. We cannot assess claims about it.
“GLP-1 agonists can decrease food cravings and help with weight loss.”
Retatrutide has been shown to produce significant weight loss, supporting the claim about GLP-1 agonists reducing food cravings.
“GLP-1 agonists can decrease alcohol cravings, drug cravings, and other types of addiction.”
While there is some research suggesting GLP-1 agonists may affect addiction pathways, the evidence is not conclusive enough to broadly claim they decrease various cravings.
“GLP-1 agonists impact the desire for love and relationships.”
There is no scientific evidence supporting the claim that GLP-1 agonists affect the desire for love or relationships.
There’s a fascinating conversation buzzing right now across neuroscience and wellness communities, around GLP-1 agonists—like Ozempic, Tirzepatide, and Retatrutide—don’t just tame food cravings and other addictions with newer research (alcohol, gambling, etc.); could they be dialing down the brain’s core “wanting” circuitry in the same reward pathways that light up during falling in love, relationships. and romantic attachment. The hypothesis is that by modulating these overlapping dopamine-driven systems, these medications could potentially blunt the intense craving and euphoria of new love or even soften feelings in existing relationships—prompting real questions about how widespread, longterm, higher dose use might reshape human connection at a neurobiological level. What do you think about this emerging discussion? Drop your thoughts (and any personal experiences) in the comments below—I’d love to hear them! 👉🏽 Comment POD below if you want me to send you my full clinical take on this and on how I’ve seen GLP-1 agonists and other peptides work the best clinically longterm. #ArtOfBeingWell